CLINICAL TRIALS PROFILE FOR VIRILON

All Clinical Trials for VIRILON

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04731376 ↗	Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone	Recruiting	Emory University	Phase 1	2021-01-25	This phase I trial investigates the safety of testosterone replacement therapy around the time of major urologic surgery (perioperative) in order to improve quality of life and post-operative outcomes such as decreased length of hospital stay, complications, and mortality in patients with low testosterone levels. Studies have demonstrated that patients undergoing testosterone replacement therapy have increased lean body mass, decreased fat mass and have improved physical function. Testosterone replacement therapy can also stimulate bone formation and may decrease the risk of fracture. Information from this trial may be used to support the incorporation of testosterone level testing and testosterone replacement into the perioperative treatment decision-making process.

Clinical Trial Conditions for VIRILON

Condition Name

Condition Name for VIRILON
Intervention	Trials
Hypogonadism	1
Malignant Urinary System Neoplasm	1
Urinary System Disorder	1
Urinary System Neoplasm	1

Condition MeSH

Condition MeSH for VIRILON
Intervention	Trials
Urologic Neoplasms	1
Urologic Diseases	1
Neoplasms	1
Hypogonadism	1

Clinical Trial Locations for VIRILON

Trials by Country

Trials by Country for VIRILON
Location	Trials
United States	1

Trials by US State

Trials by US State for VIRILON
Location	Trials
Georgia	1

Clinical Trial Progress for VIRILON

Clinical Trial Phase

Clinical Trial Phase for VIRILON
Clinical Trial Phase	Trials
Phase 1	1

Clinical Trial Status

Clinical Trial Status for VIRILON
Clinical Trial Phase	Trials
Recruiting	1

Clinical Trial Sponsors for VIRILON

Sponsor Name

Sponsor Name for VIRILON
Sponsor	Trials
Emory University	1

Sponsor Type

Sponsor Type for VIRILON
Sponsor	Trials
Other	1